UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report: June ~~May 26~~8, ~~2017~~2018

(Date of earliest event reported)

BIOLOG, INC.

(Exact name of registrant as specified in its charter)

Utah

--------------------------------

000-53696

--------------------------------

87-0279370

----------------------------------------------

(State of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

~~1223~~120 WKasson ~~Belden Avenue~~Road

~~Syeacuse,~~Suite ~~New York 12304~~382

Camillus , NY 13031

--------------------------------------------------------------

(Address of principal executive offices) (Zip Code)

(315) 701-~~10320~~1032

---------------------------------------------------------------

(Registrant'’s telephone no., including area code)

4 Colonial Avenue, Albany, NY 12203

---------------------------------------------------------------

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~ITEM~~Item 45.01 ~~CHANGES~~ INChanges ~~REGISTRANT’S~~in ~~CERTIFYING~~Control ~~ACCOUNTANT~~of Registrant.

On May 2625, 2017, ~~Board~~the ofcommon stock ~~Directors~~purchase ofagreement ~~the~~between ~~Company~~Joseph ~~approved~~C. ~~the~~Passalaqua ~~termination~~and ~~of MaloneBailey,~~Gerald ~~LLP (“MaloneBailey”)~~Fay aswas declared null and void. The share certificates were not conveyed and Joseph C. Passalaqua retained the ~~Company’s~~control ~~independent~~block ~~registered~~of ~~public~~25,006,930 ~~accounting~~common ~~firm~~shares.

~~Concurrent~~On ~~with~~January ~~this action~~1, ~~Board~~2018 ofa ~~Directors~~change in control of the ~~Company~~Registrant ~~ratified~~took ~~and~~place ~~approved~~when ~~the~~Joseph ~~appointment~~C. ~~of Boyle~~Passalaqua ~~CPA~~sold 25,006,930 shares of restricted common stock to K Marie Marketing Services, LLC ~~(“Boyle”)~~ asin exchange for certain rights granted in an agreement related to the ~~Company’s~~development ~~independent~~and ~~registered~~marketing ~~public~~of ~~accounting~~new ~~firm~~culinary ~~for~~products. Through the ~~fiscal~~exclusive ~~year~~rights ~~ending~~granted ~~December~~in 31the agreement, ~~2016~~other ~~and~~patents ~~its~~licensed ~~engagement~~by ~~agreement~~the ~~dated~~Company ~~May~~from 25other patent holders and internally developed trade secrets and products, ~~2017.~~the ~~Boyle~~Company isplans ~~located~~to atcreate ~~P.O.~~a ~~Box~~set ~~726.~~of ~~Red~~products ~~Bank,~~it ~~New~~plans ~~Jersey~~to ~~07701~~introduce into the culinary sector.

~~The~~Item ~~Company’s financial~~5.02 ~~statements~~Departures of ~~the~~Directors ~~fiscal~~or ~~years~~Certain ~~ended~~Officers; ~~December~~Election ~~31,~~of ~~2014 were~~Directors; ~~audited~~Appointment byof ~~MaloneBaileye’s~~Certain ~~report~~Officers; onCompensatory ~~our financial~~Arrangements ~~statements, which did not contain an adverse opinion, a disclaimer~~ of ~~opinion,~~Certain ~~nor was it qualified or modified as to uncertainty, audit scope or accounting principles~~Officers. MaloneBailey's report on our financial statements for the fiscal year ended December 31, 2013 through March 30, 2014, however, stated that there is substantial doubt about the Company’s ability to continue as a going concern.

~~During~~On ~~the fiscal years ended December 31, 2015 and through~~ May 2526, 2017, ~~(a)~~Gerald ~~there~~Fay ~~were~~resigned from noall ~~disagreements~~positions ~~with Enterprise~~related ~~on any matter of accounting principles or practices, financial statement disclosure, auditing scope or procedure, which disagreements, if not resolved~~ to the satisfaction of Stegman, would have caused it to make reference to the subject matter of the disagreement in connection with its report on the financial statements for such years and (b) there were no “reportable events” as described in Item 304(a)(1)(v) of Regulation S-KCompany.

~~The~~On ~~Company~~May ~~has~~26, ~~provided~~2017, ~~MaloneBailey~~Gerald ~~with~~M. ~~a copy of this Form 8-K prior to its filing with the Securities and Exchange Commission~~ (~~“SEC”~~Mike) ~~and~~Healy resigned ~~requested~~from ~~MaloneBailey~~all topositions ~~furnish~~related ~~a letter addressed~~ to the ~~SEC stating whether it agrees with the statements made above~~Company. ~~To be filed herewith as Exhibit 16.1 is a copy of MaloneBailey's letter to the SEC dated May 25, 2017.~~

~~During~~On ~~the Company's previous fiscal years ended December 31, 2016 through~~ May 2526, 2017, ~~neither~~Pat ~~the~~Scorzelli ~~Company~~resigned from ~~nor~~all ~~anyone~~positions onrelated ~~the Company's behalf consulted with MaloneBailey regarding either (i) the application of accounting principles~~ to ~~a specified transaction, either completed or proposed, or~~ the ~~type of audit opinion that might be rendered on the~~ Company~~'s financial statements or (ii) any matter that was either the subject of a disagreement or a reportable event as defined in Item 304(a)(1)(v) of Regulation S-K.~~

~~The~~On ~~Company~~May ~~has~~26, ~~authorized~~2017, ~~MaloneBailey~~Shelli toFields ~~respond~~was ~~fully~~elected as toa ~~all~~Director ~~inquiries~~and appointed as CEO of ~~Boyle~~the Company.

~~ITEM~~On ~~5.02 DEPARTURES~~August OF9, ~~DIRECTORS OR~~2017, ~~CERTAIN~~Shelli ~~OFFICERS; ELECTION~~Fields OFresigned as ~~DIRECTORS; APPOINTMENT~~CEO OFof ~~CERTAIN~~the ~~OFFICERS;~~Company ~~COMPENSATORY~~but ~~ARRANGEMENTS~~remained OFas ~~CERTAIN~~a ~~OFFICERS~~director and was elected as Secretary.

On ~~May~~August 269, 2017 ~~In accordance with the Special Meeting of the Shareholders~~, ~~Gerald~~Craig ~~Fay,~~Machado ~~Pat Scorzelli and Mike Healey resigned as Director and Officer of the Registrant and Shelli Fields of Syracuse, New York~~ was appointed ~~elected~~ as a Director, and ~~appointed as~~ Chief Executive Officer of the ~~Registrant~~Company.

~~ITEM~~On August 9, 2017, Joseph J.~~01 FINANCIAL~~ ~~STATEMENTS~~Passalaqua was ~~AND~~appointed ~~EXHIBITS~~Director and Chief Financial Officer of the Company.

~~(d)~~On ~~Exhibits~~April 20, 2018, Craig Machado resigned as Chief Executive Officer of the Company.

Exhibit No.	Description of Exhibit
16.1	Letter from Auditors to the Securities aNd Exchange Comission dated May 26, 2017

On May 30, 2018, Bruce w. Bauer was appointed Chief Executive Officer of the Company.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized .

		BIOLOG, INC.
		(Registrant)
	Date: May 26, 2017	By: /s/ SHELLI FIELDS
	Date: June 8, 2018	By: /s/ BRUCE BAUER
		Shelli Fields
		CEO
		Chief Executive Officer and
		Director
		(Duly Authorized Officer)

Filing Compare · Biolog, Inc